skip to main content
Home
About Us
Leadership & Advisors
Events & Media
Contact Us
Products
Transplant
VitaGraft Liver
VitaGraft Kidney
Oncology
DetermaIO
DetermaCNI
Publications
Biopharma Services
Investors
Oncocyte Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Corporate Governance
Information Request
Contact Us
Go to...
Home
About Us
Leadership & Advisors
Events & Media
Contact Us
Products
Transplant
VitaGraft Liver
VitaGraft Kidney
Oncology
DetermaIO
DetermaCNI
Publications
Biopharma Services
Investor
Oncocyte Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Corporate Governance
Board of Directors
Committees
Governance Documents
Board Diversity Matrix
Information Request
Contact Us
Email Alerts
Contact Us
.
Home
>
Investors
>
News Releases
>
2023
Oncocyte Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Corporate Governance
Board of Directors
Committees
Governance Documents
Board Diversity Matrix
Information Request
Contact Us
Email Alerts
Print
Share page
Email
Facebook
Twitter
News Releases
Register for email alerts
.
All Categories
All Categories
General
Earnings
Corporate News
Date Descending
Date Descending
Date Ascending
2023
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Date
Title
Document
Date
Mar 29, 2023
Title
Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call
Document
PDF
Date
Mar 15, 2023
Title
Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results
Document
PDF
Date
Mar 02, 2023
Title
Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer
Document
PDF
Date
Feb 22, 2023
Title
Oncocyte Completes Razor Genomics Transaction
Document
PDF
<<
<
1
2
3
>
>>